Tilray Brands, Inc.
corporate_fare Company Profile
Tilray Brands, Inc. (NASDAQ:TLRY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 32 items for TLRY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for TLRY spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Tilray Consolidates Canadian Cannabis Ops, Lifts FY27 EBITDA Guidance to $70M-$75M
- Tilray Cuts 40% of U.S. Breweries, Targets $20M Annual Savings
- Tilray Secures U.S. Rights to Carlsberg's 1664 Beers in Profit-Sharing Deal
- Tilray Q1 Loss Widens; Credit Facility Access Restricted by New Covenant Amendment
- Tilray Q1 Revenue Jumps 23% to $257.1M, Reaffirms FY27 EBITDA Guidance
Financial Snapshot
Short Interest & Short Volume
4.76 days to coverFINRA reported short interest of 19,539,742 shares in TLRY as of the October 30, 2026 settlement, a 9.2% decrease from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 53.5% of TLRY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for TLRY, detected from its recent SEC filings · based on capital-structure filings through 2026-09-14.
Fourth Debt-for-Equity Exchange · Cumulative Dilution from Exchanges
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →